US Stock MarketDetailed Quotes
TCBP TC BioPharm
- 0.6500
- +0.1810+38.59%
Close Dec 18 16:00 ET
- 0.6070
- -0.0430-6.62%
Pre 07:04 ET
5.34MMarket Cap0.00P/E (TTM)
0.8210High0.5560Low29.34MVolume0.8043Open0.4690Pre Close25.28MTurnover357.61%Turnover Ratio0.00P/E (Static)8.21MShares41.500052wk High2.12P/B5.33MFloat Cap0.435952wk Low--Dividend TTM8.21MShs Float35000.0000Historical High--Div YieldTTM56.50%Amplitude0.4350Historical Low0.8610Avg Price1Lot Size
About TC BioPharm Company
TC Biopharm (Holdings) Plc is a clinical-stage biopharmaceutical company, which engages in the development of novel immunotherapy products based on its proprietary allogeneic gamma delta T cell platform. The company was founded by Michael Leek and Angela Scott in 2013 and is headquartered in Motherwell, the United Kingdom.
Company Profile
SymbolTCBP
Company NameTC BioPharm
Listing DateFeb 11, 2022
Issue Price4.24
Founded2021
CEOMr. Bryan Kobel
MarketNASDAQ
Employees41
Securities TypeDR
ADS Ratio1.0 : 200.0
Fiscal Year Ends12-31
AddressMaxim Park 1,2 Parklands Way,Holytown
CityMotherwell
ProvinceNK
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeML1 4WR
Phone44-141-433-7557
Websitehttp://www.tcbiopharm.com
Company Executives
- Name
- Position
- Salary
- Bryan Kobel
- Chief Executive Officer and Director
- --
- Martin Thorp
- Chief Financial Officer and Director
- --
- Arlene M. Morris
- Independent Director
- --
- Anthony James Culverwell
- Independent Director
- --
Heat List
US
Overall
Symbol
Price
% Chg
No Data
